Articles de revues sur le sujet « Development of disease »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Development of disease ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.
Nuriddinovna, INDIAMINOVA Gavkhar. "The Likelihood of Developing Periodontal Disease in Patients with Cardiovascular Diseases." American Journal Of Social Sciences And Humanity Research 5, no. 5 (2025): 131–34. https://doi.org/10.37547/ajsshr/volume05issue05-31.
Texte intégralWalter, Michael A., and Peter N. Goodfellow. "Disease and development." Nature 355, no. 6361 (1992): 590–91. http://dx.doi.org/10.1038/355590a0.
Texte intégralSobue, Gen. "Development of disease-modifying therapy for neurodegenerative diseases." Rinsho Shinkeigaku 51, no. 11 (2011): 821–24. http://dx.doi.org/10.5692/clinicalneurol.51.821.
Texte intégralGuo, Dugang, Jun Liu, and Xuewei Wang. "On development of multi-resolution detector for tomato disease diagnosis." Journal of Intelligent & Fuzzy Systems 41, no. 6 (2021): 6461–71. http://dx.doi.org/10.3233/jifs-210262.
Texte intégralIrami, Araujo-Filho, Dantas Freire Artur, Araujo-Neto Irami, et al. "Kikuchi-Fujimoto disease: case report and review." International Journal of Medical Reviews and Case Reports 1, no. 1 (2017): 6–10. https://doi.org/10.5455/IJMRCR.kikuchi-fujimoto-disease.
Texte intégralBankina, B. "Tan spot development peculiarities in Latvia." Plant Protection Science 38, SI 2 - 6th Conf EFPP 2002 (2017): 381–83. http://dx.doi.org/10.17221/10497-pps.
Texte intégralGaras, Antonios, Sophie Guthmuller, and Athanasios Lapatinas. "The development of nations conditions the disease space." PLOS ONE 16, no. 1 (2021): e0244843. http://dx.doi.org/10.1371/journal.pone.0244843.
Texte intégralL. Zoler, Mitchel. "Alzheimer's Disease Drug Development Targets Disease Modification." Caring for the Ages 16, no. 9 (2015): 4. http://dx.doi.org/10.1016/j.carage.2015.08.005.
Texte intégralHines, Pamela J. "From development to disease." Science 371, no. 6527 (2021): 358.10–360. http://dx.doi.org/10.1126/science.371.6527.358-j.
Texte intégralWhitsett, Jeffrey A., and Timothy E. Weaver. "Alveolar Development and Disease." American Journal of Respiratory Cell and Molecular Biology 53, no. 1 (2015): 1–7. http://dx.doi.org/10.1165/rcmb.2015-0128ps.
Texte intégralBloom, David E., David Canning, and Günther Fink. "Disease and Development Revisited." Journal of Political Economy 122, no. 6 (2014): 1355–66. http://dx.doi.org/10.1086/677189.
Texte intégralBujosa, Francesc. "Economic development and disease." Lancet 354 (December 1999): SIV19. http://dx.doi.org/10.1016/s0140-6736(99)90362-8.
Texte intégralMillen, Kathleen J., and Joseph G. Gleeson. "Cerebellar development and disease." Current Opinion in Neurobiology 18, no. 1 (2008): 12–19. http://dx.doi.org/10.1016/j.conb.2008.05.010.
Texte intégralMiller, Geoffrey. "Neuromuscular development and disease." Neuromuscular Disorders 3, no. 1 (1993): 90. http://dx.doi.org/10.1016/0960-8966(93)90050-t.
Texte intégralCano, David A., Matthias Hebrok, and Martin Zenker. "Pancreatic Development and Disease." Gastroenterology 132, no. 2 (2007): 745–62. http://dx.doi.org/10.1053/j.gastro.2006.12.054.
Texte intégralPanos, Leonidas D. "Alzheimer's Disease Drug Development." Current Alzheimer Research 21, no. 10 (2025): 691–92. https://doi.org/10.2174/156720502110250304104224.
Texte intégralFURUKAWA, Fumiko, Noriyoshi TANAKA, Mitsunori MIYASHITA, Haruko SHIKIMORI, and Hiroaki KANAZAWA. "A Protective Mattress Development for Patients with Peripheral Vascular Disease." Japanese Journal of Ergonomics 48, no. 4 (2012): 196–203. http://dx.doi.org/10.5100/jje.48.196.
Texte intégralKatu, Amina H. "The Role of Epigenetics in Disease Development." RESEARCH INVENTION JOURNAL OF PUBLIC HEALTH AND PHARMACY 3, no. 2 (2024): 41–44. http://dx.doi.org/10.59298/rijpp/2024/3234144.
Texte intégralKadirovna, Muratova Saodat, Shukurova Nodira Tillayevna, Baratov Bobur, and Teshayev Shoxjahon. "PREDICTIVE MODELING OF THE PROBABILITY OF DEVELOPING PERIODONTAL DISEASES IN PATIENTS WITH CARDIOVASCULAR DISEASE." European International Journal of Multidisciplinary Research and Management Studies 4, no. 4 (2024): 65–70. http://dx.doi.org/10.55640/eijmrms-04-04-10.
Texte intégralMurrell, Adele, Paul J. Hurd, and Ian C. Wood. "Epigenetic Mechanisms in Development and Disease." Biochemical Society Transactions 41, no. 3 (2013): 697–99. http://dx.doi.org/10.1042/bst20130051.
Texte intégralSaad, Sonia, and Hui Chen. "Diet and Disease Development: Mechanisms, Prevention, and Treatment." Nutrients 16, no. 21 (2024): 3676. http://dx.doi.org/10.3390/nu16213676.
Texte intégralConesa, Xavier, Xavier González, Eduard Siles, Fèlix Parals, and Josep Novell. "Simultaneous Development of Dieterich Disease and Freiberg Disease." Journal of Foot and Ankle Surgery 52, no. 3 (2013): 389–92. http://dx.doi.org/10.1053/j.jfas.2012.12.014.
Texte intégralEspay, Alberto J., Lorraine V. Kalia, Ziv Gan-Or, et al. "Disease modification and biomarker development in Parkinson disease." Neurology 94, no. 11 (2020): 481–94. http://dx.doi.org/10.1212/wnl.0000000000009107.
Texte intégralVenkatesh, Vaibhav, Deena C. Mendez, Rajshekhar T S, and Sharath Balakrishna. "Molecular factors in the development of vitiligo." JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES 09, no. 3 (2019): 61–68. http://dx.doi.org/10.58739/jcbs/v09i3.8.
Texte intégralWenda, Alex, Nanda Putri Miefthawati, and Mas’ud Zein. "The Development of Diseases Identification System in Paddy Plant Using Image Processing Technique." Proceeding International Conference on Science and Engineering 2 (March 1, 2019): 231–36. http://dx.doi.org/10.14421/icse.v2.92.
Texte intégralLundstrom, Kenneth. "Epigenetics, Nutrition, Disease and Drug Development." Current Drug Discovery Technologies 16, no. 4 (2019): 386–91. http://dx.doi.org/10.2174/1570163815666180419154954.
Texte intégralDivvela, Satya Srirama Karthik, Darius Saberi, and Beate Brand-Saberi. "Atoh8 in Development and Disease." Biology 11, no. 1 (2022): 136. http://dx.doi.org/10.3390/biology11010136.
Texte intégralHeward, Joanne, and Stephen C. L. Gough. "Genetic Susceptibility to the Development of Autoimmune Disease." Clinical Science 93, no. 6 (1997): 479–91. http://dx.doi.org/10.1042/cs0930479.
Texte intégralCurrer, Currer. "Fetal Exposure to Arsenic Results in the Development of Multiple Risk Factors for the Development of Metabolic Syndrome." Clinical and Medical Research and Studies 2, no. 4 (2023): 1–2. https://doi.org/10.59468/2836-8525/034.
Texte intégralLiersch, Ruediger, and Michael Detmar. "Lymphangiogenesis in development and disease." Thrombosis and Haemostasis 98, no. 08 (2007): 304–10. http://dx.doi.org/10.1160/th07-04-0238.
Texte intégralHan, Hyeseung, and Daeun Park. "Development and Validation of Disease Mindset Measurement Scale." Korean Association of Health and Medical Sociology 64 (December 31, 2023): 63–97. http://dx.doi.org/10.37243/kahms.2023.64.63.
Texte intégralGoncharov, V. E., V. M. Kozidubova, S. M. Doluda, E. N. Barycheva, and A. V. Gurnickiy. "Family impact on disease development." Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2020, no. 2 (2020): 75–79. http://dx.doi.org/10.15407/internalmed2020.02.075.
Texte intégralChaitra, P., and NandaKishore Bala. "Onychomycosis: Insights in disease development." Muller Journal of Medical Sciences and Research 5, no. 2 (2014): 101. http://dx.doi.org/10.4103/0975-9727.135735.
Texte intégralApter, Jeffrey T. "New Drug Development --- Alzheimer' Disease." Neuropsychopharmacology 11, no. 4 (1994): 264. http://dx.doi.org/10.1038/sj.npp.1380130.
Texte intégralVANČURA, A., and M. CHYTIL. "The Development of Hypertensive Disease." Acta Medica Scandinavica 154, S312 (2009): 109–13. http://dx.doi.org/10.1111/j.0954-6820.1956.tb16956.x.
Texte intégralBarta, Andrea, and Michael F. Jantsch. "RNA in Disease and development." RNA Biology 14, no. 5 (2017): 457–59. http://dx.doi.org/10.1080/15476286.2017.1316929.
Texte intégralRoses, Allen D., and Menelas N. Pangalos. "Drug Development and Alzheimer Disease." American Journal of Geriatric Psychiatry 11, no. 2 (2003): 123–30. http://dx.doi.org/10.1097/00019442-200303000-00003.
Texte intégralGoshomi, Unice. "Fetal development and coronavirus disease." African Journal of Midwifery and Women's Health 14, no. 3 (2020): 1. http://dx.doi.org/10.12968/ajmw.2020.0041.
Texte intégralAlderton, Gemma. "Improving Alzheimer's disease drug development." Science 362, no. 6420 (2018): 1259.14–1261. http://dx.doi.org/10.1126/science.362.6420.1259-n.
Texte intégralFerreira, A. "Development of renal bone disease." European Journal of Clinical Investigation 36, s2 (2006): 2–12. http://dx.doi.org/10.1111/j.1365-2362.2006.01661.x.
Texte intégralGhosh, Anirban, Wolfgang J. Streit, Luisa Minghetti, and Anirban Basu. "Microglia in Development and Disease." Clinical and Developmental Immunology 2013 (2013): 1–2. http://dx.doi.org/10.1155/2013/736459.
Texte intégralGomase, Virendra S., and Akshay N. Parundekar. "microRNA: human disease and development." International Journal of Bioinformatics Research and Applications 5, no. 5 (2009): 479. http://dx.doi.org/10.1504/ijbra.2009.028678.
Texte intégralLehmann, Ordan J., Jane C. Sowden, Peter Carlsson, Tim Jordan, and Shomi S. Bhattacharya. "Fox's in development and disease." Trends in Genetics 19, no. 6 (2003): 339–44. http://dx.doi.org/10.1016/s0168-9525(03)00111-2.
Texte intégralKo, Myunggon, Dong H. Sohn, Heekyoung Chung, and Rho H. Seong. "Chromatin remodeling, development and disease." Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 647, no. 1-2 (2008): 59–67. http://dx.doi.org/10.1016/j.mrfmmm.2008.08.004.
Texte intégralHüppi, Petra, Stephane Sizonenko, and Maurizio Amato. "Lung Disease and Brain Development." Neonatology 89, no. 4 (2006): 284–97. http://dx.doi.org/10.1159/000092865.
Texte intégralSonnenberg, Arnoud, and Ronald K. H. Liem. "Plakins in development and disease." Experimental Cell Research 313, no. 10 (2007): 2189–203. http://dx.doi.org/10.1016/j.yexcr.2007.03.039.
Texte intégralRoque, M., and A. Craveiro. "Psychiatric Development in Huntington Disease." European Psychiatry 24, S1 (2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)71201-5.
Texte intégralDurbeej, Madeleine, Michael D. Henry, and Kevin P. Campbell. "Dystroglycan in development and disease." Current Opinion in Cell Biology 10, no. 5 (1998): 594–601. http://dx.doi.org/10.1016/s0955-0674(98)80034-3.
Texte intégralVogel, Tanja, and Silke Lassmann. "Epigenetics: development, dynamics and disease." Cell and Tissue Research 356, no. 3 (2014): 451–55. http://dx.doi.org/10.1007/s00441-014-1916-7.
Texte intégralMilligan, Paul, and Michael Pugh Thomas. "Relationships between development and disease." Environmentalist 6, no. 2 (1986): 129–40. http://dx.doi.org/10.1007/bf02277236.
Texte intégral